Physician Assistant in Woodland Park, NJ Accepting Medicare
1 Physician Assistant nurses found. Showing 1 - 1
 Ms. Michelle Elizabeth Birman, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 12 Bolds Ln, Woodland Park, NJ 07424 Phone: 347-225-5089 |
News Archive
Researchers discover new mechanism that contributes to airway hyperresponsiveness in asthma
In asthma, the airways become hyperresponsive. Researchers from Uppsala University have found a new mechanism that contributes to, and explains, airway hyperresponsiveness.
Global guidance on bednet purchasing needed, analysis suggests
"According to analysis led by Kanika Bahl and Pooja Shaw of Results for Development's (R4D's) Market Dynamics team, improved global incentives and information on cost-effectiveness could save the fight against malaria up to $630 million over the next five years and encourage manufacturers to produce better-performing nets," Bahl, a managing director for R4D, and Shaw, a program officer in the Market Dynamics Practice at R4D, write in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
Researchers identify neurons that regulate nausea-like responses in mice
At some point, everyone experiences nausea. Whether it occurs after unwisely eating a week-old slice of pizza or as an accompaniment to a serious infection, that queasy, unsettling sensation centered around the stomach is a signal that something is amiss within the body and typically portends a bout of vomiting.
Researchers examine new zinc-based bioabsorbable stents
In 2012, more than 3 million people had stents inserted in their coronary arteries. These tiny mesh tubes prop open blood vessels healing from procedures like a balloon angioplasty, which widens arteries blocked by clots or plaque deposits. After about six months, most damaged arteries are healed and stay open on their own. The stent, however, is there for a lifetime.
FDA to review potential anti-arrhythmic claims for Ranexa
CV Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has notified the Company that it will evaluate the approval of potential anti-arrhythmic claims for Ranexa (ranolazine extended-release tablets) as part of its ongoing review of the Company's supplemental new drug application (sNDA).
› Verified 7 days ago